{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:04:43Z","timestamp":1780113883658,"version":"3.54.0"},"reference-count":84,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,5,27]]},"DOI":"10.1248\/bpb.b26-00025","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:09:55Z","timestamp":1779833395000},"page":"872-887","source":"Crossref","is-referenced-by-count":0,"title":["Modeling Hypertrophic Cardiomyopathy-Related &lt;i&gt;MYH7&lt;\/i&gt; Variants: Insights into Structural Changes and Cardiovascular Drug-Binding Affinities"],"prefix":"10.1248","volume":"49","author":[{"given":"Nadia","family":"Widjaja","sequence":"first","affiliation":[{"name":"School of Bioscience, Technology, and Innovation, Atma Jaya Catholic University of Indonesia, South Jakarta, DKI Jakarta 12930, Indonesia"},{"name":"Dexa Omic Sciences (Dexomics), Dexa Medica, South Tangerang, Banten 15222, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doni","family":"Dermawan","sequence":"additional","affiliation":[{"name":"Dexa Omic Sciences (Dexomics), Dexa Medica, South Tangerang, Banten 15222, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santi","family":"Tan","sequence":"additional","affiliation":[{"name":"Dexa Omic Sciences (Dexomics), Dexa Medica, South Tangerang, Banten 15222, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefeny T.","family":"Simatupang","sequence":"additional","affiliation":[{"name":"School of Bioscience, Technology, and Innovation, Atma Jaya Catholic University of Indonesia, South Jakarta, DKI Jakarta 12930, Indonesia"},{"name":"Dexa Omic Sciences (Dexomics), Dexa Medica, South Tangerang, Banten 15222, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Yulandi","sequence":"additional","affiliation":[{"name":"School of Bioscience, Technology, and Innovation, Atma Jaya Catholic University of Indonesia, South Jakarta, DKI Jakarta 12930, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R.","family":"Tjandrawinata","sequence":"additional","affiliation":[{"name":"Dexa Omic Sciences (Dexomics), Dexa Medica, South Tangerang, Banten 15222, Indonesia"},{"name":"Center for Pharmaceutical and Nutraceutical Research and Policy (CPNRP), Atma Jaya Catholic University of Indonesia, South Jakarta, DKI Jakarta 12930, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Fifer MA, Vlahakes GJ. Management of symptoms in hypertrophic cardiomyopathy. <i>Circulation<\/i>, <b>117<\/b>, 429\u2013439 (2008).","DOI":"10.1161\/CIRCULATIONAHA.107.694158"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Marston S, Copeland O, Gehmlich K, Schlossarek S, Carrier L. How do <i>MYBPC3<\/i> mutations cause hypertrophic cardiomyopathy? <i>J. Muscle Res. Cell Motil.<\/i>, <b>33<\/b>, 75\u201380 (2012).","DOI":"10.1007\/s10974-011-9268-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. <i>J. Am. Coll. Cardiol.<\/i>, <b>65<\/b>, 1249\u20131254 (2015).","DOI":"10.1016\/j.jacc.2015.01.019"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Argir\u00f2 A, Zampieri M, Berteotti M, Marchi A, Tassetti L, Zocchi C, Iannone L, Bacchi B, Cappelli F, Stef\u00e0no P, Marchionni N, Olivotto I. Emerging medical treatment for hypertrophic cardiomyopathy. <i>J. Clin. Med.<\/i>, <b>10<\/b>, 951 (2021).","DOI":"10.3390\/jcm10050951"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Carrier L. Targeting the population for gene therapy with <i>MYBPC3<\/i>. <i>J. Mol. Cell. Cardiol.<\/i>, <b>150<\/b>, 101\u2013108 (2021).","DOI":"10.1016\/j.yjmcc.2020.10.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: A meta-analysis on 7675 individuals. <i>Clin. Res. Cardiol.<\/i>, <b>107<\/b>, 30\u201341 (2018).","DOI":"10.1007\/s00392-017-1155-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Witjas-Paalberends ER, Piroddi N, Stam K, Van Dijk SJ, Oliviera VS, Ferrara C, Scellini B, Hazebroek M, Ten Cate FJ, Van Slegtenhorst M, Dos Remedios C, Niessen HWM, Tesi C, Stienen GJM, Heymans S, Michels M, Poggesi C, Van Der Velden J. Mutations in <i>MYH7<\/i> reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy. <i>Cardiovasc. Res.<\/i>, <b>99<\/b>, 432\u2013441 (2013).","DOI":"10.1093\/cvr\/cvt119"},{"key":"8","unstructured":"8) De Frutos F, Ochoa JP, Navarro-Pe\u00f1alver M, Baas A, Bjerre JV, Zorio E, M\u00e9ndez I, Lorca R, Verdonschot JAJ, Garc\u00eda-Granja PE, Bilinska Z, Fatkin D, Fuentes-Ca\u00f1amero ME, Garc\u00eda-Pinilla JM, Garc\u00eda-\u00c1lvarez MI, Girolami F, Barriales-Villa R, D\u00edez-L\u00f3pez C, Lopes LR, Wahbi K, Garc\u00eda-\u00c1lvarez A, Rodr\u00edguez-S\u00e1nchez I, <i>et al<\/i>. Natural history of <i>MYH7<\/i>-related dilated cardiomyopathy. <i>J. Am. Coll. Cardiol.<\/i>, <b>80<\/b>, 1447\u20131461 (2022)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Li X, Tang J, Li J, Lin S, Wang T, Zhou K, Li Y, Hua Y. Genetic clues on implantable cardioverter-defibrillator placement in young-age hypertrophic cardiomyopathy: a case report of novel <i>MYH7<\/i> mutation and literature review. <i>Front. Cardiovasc. Med.<\/i>, <b>8<\/b>, 810291 (2021).","DOI":"10.3389\/fcvm.2021.810291"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Jord\u00e0 P, Oudit GY, Tadros R. Unraveling the genetic substrate and phenotypic variability of hypertrophic cardiomyopathy: a role for desmosome gene variants? Can. <i>J. Cardiol.<\/i>, <b>38<\/b>, 3\u20135 (2022).","DOI":"10.1016\/j.cjca.2021.11.013"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Green EM, Wakimoto H, Anderson RL, Evanchik MJ, Gorham JM, Harrison BC, Henze M, Kawas R, Oslob JD, Rodriguez HM, Song Y, Wan W, Leinwand LA, Spudich JA, McDowell RS, Seidman JG, Seidman CE. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. <i>Science<\/i>, <b>351<\/b>, 617\u2013621 (2016).","DOI":"10.1126\/science.aad3456"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mori AA, Castro LRD, Bortolin RH, Bastos GM, Oliveira VFD, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Pach\u00f3n-Mateos JC, Correia EDB, Sousa AGDMR, Bri\u00f3n M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in <i>MYH7, MYBPC3<\/i> and <i>TNNT2<\/i> with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. <i>Forensic Sci. Int. Genet.<\/i>, <b>52<\/b>, 102478 (2021).","DOI":"10.1016\/j.fsigen.2021.102478"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wang J, Wan K, Sun J, Li W, Liu H, Han Y, Chen Y. Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single <i>MYH7<\/i> mutation. <i>Sci. Rep.<\/i>, <b>8<\/b>, 973 (2018).","DOI":"10.1038\/s41598-018-19372-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Margara F, Psaras Y, Wang ZJ, Schmid M, Doste R, Garfinkel AC, Repetti GG, Seidman JG, Seidman CE, Rodriguez B, Toepfer CN, Bueno-Orovio A. Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy. <i>Sci. Rep.<\/i>, <b>12<\/b>, 22501 (2022).","DOI":"10.1038\/s41598-022-26889-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Zampieri M, Berteotti M, Ferrantini C, Tassetti L, Gabriele M, Tomberli B, Castelli G, Cappelli F, Stef\u00e0no P, Marchionni N, Coppini R, Olivotto I. Pathophysiology and treatment of hypertrophic cardiomyopathy: New perspectives. <i>Curr. Heart Fail. Rep.<\/i>, <b>18<\/b>, 169\u2013179 (2021).","DOI":"10.1007\/s11897-021-00523-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nag S, Gollapudi SK, Del Rio CL, Spudich JA, McDowell R. Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients. <i>Sci. Adv.<\/i>, <b>9<\/b>, eabo7622 (2023).","DOI":"10.1126\/sciadv.abo7622"},{"key":"17","unstructured":"17) Bateman A, Martin M-J, Orchard S, <i>et al<\/i>. UniProt: the Universal Protein Knowledgebase in 2023. <i>Nucleic Acids Res.<\/i>, <b>51<\/b>(D1), D523\u2013D531 (2023)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Keskin Karakoyun H, Y\u00fcksel \u015eK, Amanoglu I, Naserikhojasteh L, Ye\u015filyurt A, Yak\u0131c\u0131er C, Timu\u00e7in E, Akyerli CB. Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer. <i>Front. Genet.<\/i>, <b>14<\/b>, 1052383 (2023).","DOI":"10.3389\/fgene.2023.1052383"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Henrie A, Hemphill SE, Ruiz-Schultz N, Cushman B, DiStefano MT, Azzariti D, Harrison SM, Rehm HL, Eilbeck K. ClinVar Miner: demonstrating utility of a web-based tool for viewing and filtering ClinVar data. <i>Hum. Mutat.<\/i>, <b>39<\/b>, 1051\u20131060 (2018).","DOI":"10.1002\/humu.23555"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Roza GR, Da Costa CCP, De Lima NS, Da Silva Reis AA, Da Silva Santos R. <i>In silico<\/i> evaluation of effect and molecular modeling of SNPs in genes related to amyotrophic lateral sclerosis. <i>Sclerosis<\/i>, <b>3<\/b>, 27 (2025).","DOI":"10.3390\/sclerosis3030027"},{"key":"21","unstructured":"21) Abramson J, Adler J, Dunger J, <i>et al<\/i>. Accurate structure prediction of biomolecular interactions with AlphaFold 3. <i>Nature<\/i>, <b>630<\/b>, 493\u2013500 (2024)."},{"key":"22","unstructured":"22) EMBL-EBI. \u201cHow to assess the quality of AlphaFold 3 predictions.\u201d: &lt;https:\/\/www.ebi.ac.uk\/training\/online\/courses\/alphafold\/alphafold-3-and-alphafold-server\/how-to-assess-the-quality-of-alphafold-3-predictions\/&gt;, accessed 12 January, 2026."},{"key":"23","unstructured":"23) Schr\u00f6dinger. <i>The PyMOL Molecular Graphics System<\/i>, Schr\u00f6dinger, New York, 2023."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Xu J, Zhang Y. How significant is a protein structure similarity with TM-score = 0.5? <i>Bioinformatics<\/i>, <b>26<\/b>, 889\u2013895 (2010).","DOI":"10.1093\/bioinformatics\/btq066"},{"key":"25","unstructured":"25) EMBL-EBI. \u201cAlphaFold: Glossary of terms.\u201d: &lt;https:\/\/www.ebi.ac.uk\/training\/online\/courses\/alphafold\/glossary-of-terms\/&gt;, accessed 12 January, 2026."},{"key":"26","unstructured":"26) EMBL-EBI. \u201cPAE: A measure of global confidence in AlphaFold2 predictions.\u201d: &lt;https:\/\/www.ebi.ac.uk\/training\/online\/courses\/alphafold\/inputs-and-outputs\/evaluating-alphafolds-predicted-structures-using-confidence-scores\/pae-a-measure-of-global-confidence-in-alphafold-predictions\/&gt;, accessed 12 January, 2026."},{"key":"27","unstructured":"27) EMBL-EBI. \u201cpLDDT: Understanding local confidence.\u201d: &lt;https:\/\/www.ebi.ac.uk\/training\/online\/courses\/alphafold\/inputs-and-outputs\/evaluating-alphafolds-predicted-structures-using-confidence-scores\/plddt-understanding-local-confidence\/&gt;, accessed 12 January, 2026."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Williams CJ, Chen VB, Richardson DC, Richardson JS. Categorizing prediction modes within low-pLDDT regions of AlphaFold2 structures: near-predictive, pseudostructure and barbed wire. <i>Acta Crystallogr. D Struct. Biol.<\/i>, <b>81<\/b>, 558\u2013572 (2025).","DOI":"10.1107\/S2059798325007843"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Zhang Y, Skolnick J. Scoring function for automated assessment of protein structure template quality. <i>Proteins<\/i>, <b>57<\/b>, 702\u2013710 (2004).","DOI":"10.1002\/prot.20264"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Waterhouse AM, Studer G, Robin X, Bienert S, Tauriello G, Schwede T. The structure assessment web server: for proteins, complexes and more. <i>Nucleic Acids Res.<\/i>, <b>52<\/b>(W1), W318\u2013W323 (2024).","DOI":"10.1093\/nar\/gkae270"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, Verma V, Keedy DA, Hintze BJ, Chen VB, Jain S, Lewis SM, Arendall WB 3rd, Snoeyink J, Adams PD, Lovell SC, Richardson JS, Richardson DC. MolProbity: more and better reference data for improved all-atom structure validation. <i>Protein Sci.<\/i>, <b>27<\/b>, 293\u2013315 (2018).","DOI":"10.1002\/pro.3330"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. <i>Acta Crystallogr. D Biol. Crystallogr.<\/i>, <b>66<\/b>, 12\u201321 (2010).","DOI":"10.1107\/S0907444909042073"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hintze BJ, Lewis SM, Richardson JS, Richardson DC. Molprobity\u2019s ultimate rotamer-library distributions for model validation: MolProbity\u2019s ultimate rotamer-library. <i>Proteins<\/i>, <b>84<\/b>, 1177\u20131189 (2016).","DOI":"10.1002\/prot.25039"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Miwa K, Guo Y, Hata M, Hirano Y, Yamamoto N, Hoshino T. <i>In silico<\/i> identification of inhibitory compounds for SARS-Cov-2 papain-like protease. <i>Chem. Pharm. Bull.<\/i>, <b>71<\/b>, 897\u2013905 (2023).","DOI":"10.1248\/cpb.c23-00622"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wang Y, Zhao Y, Wei C, Tian N, Yan H. 4D-QSAR molecular modeling and analysis of flavonoid derivatives as acetylcholinesterase inhibitors. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 999\u20131006 (2021).","DOI":"10.1248\/bpb.b21-00265"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Jumper J, Evans R, Pritzel A, <i>et al<\/i>. Highly accurate protein structure prediction with AlphaFold. <i>Nature<\/i>, <b>596<\/b>, 583\u2013589 (2021).","DOI":"10.1038\/s41586-021-03819-2"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Laskowski RA, Jab\u0142o\u0144ska J, Pravda L, Va\u0159ekov\u00e1 RS, Thornton JM. PDBsum: structural summaries of PDB entries. <i>Protein Sci.<\/i>, <b>27<\/b>, 129\u2013134 (2018).","DOI":"10.1002\/pro.3289"},{"key":"38","unstructured":"38) Rose PW, Prli\u0107 A, Altunkaya A, <i>et al<\/i>. The RCSB Protein Data Bank: integrative view of protein, gene and 3D structural information. <i>Nucleic Acids Res.<\/i>, <b>45<\/b>(D1), D271\u2013D281 (2017)."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. PubChem 2023 update. <i>Nucleic Acids Res.<\/i>, <b>51<\/b>(D1), D1373\u2013D1380 (2023).","DOI":"10.1093\/nar\/gkac956"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Wallerstein J, Akke M. Minute additions of DMSO affect protein dynamics measurements by NMR relaxation experiments through significant changes in solvent viscosity. <i>Chemphyschem<\/i>, <b>20<\/b>, 326\u2013332 (2019).","DOI":"10.1002\/cphc.201800626"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Lii J, Gallion S, Bender C, Wikstr\u00f6m H, Allinger NL, Flurchick KM, Teeter MM. Molecular mechanics (MM2) calculations on peptides and on the protein Crambin using the CYBER 205. <i>J. Comput. Chem.<\/i>, <b>10<\/b>, 503\u2013513 (1989).","DOI":"10.1002\/jcc.540100408"},{"key":"42","unstructured":"42) Chem3D Ultra, PerkinElmer, Inc., Waltham, MA, USA, 2022."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Honorato RV, Trellet ME, Jim\u00e9nez-Garc\u00eda B, Schaarschmidt JJ, Giulini M, Reys V, Koukos PI, Rodrigues JPGLM, Karaca E, Van Zundert GCP, Roel-Touris J, Van Noort CW, Jandov\u00e1 Z, Melquiond ASJ, Bonvin AMJJ. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. <i>Nat. Protoc.<\/i>, <b>19<\/b>, 3219\u20133241 (2024).","DOI":"10.1038\/s41596-024-01011-0"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Vangone A, Bonvin A. PRODIGY: A contact-based predictor of binding affinity in protein-protein complexes. <i>Bio Protoc.<\/i>, <b>7<\/b>, e2124 (2017).","DOI":"10.21769\/BioProtoc.2124"},{"key":"45","unstructured":"45) BIOVIA. Dassault Syst\u00e8mes, San Diego, 2024."},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera\u2014a visualization system for exploratory research and analysis. <i>J. Comput. Chem.<\/i>, <b>25<\/b>, 1605\u20131612 (2004).","DOI":"10.1002\/jcc.20084"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. <i>J. Comput. Chem.<\/i>, <b>30<\/b>, 2785\u20132791 (2009).","DOI":"10.1002\/jcc.21256"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. <i>J. Comput. Chem.<\/i>, <b>19<\/b>, 1639\u20131662 (1998).","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) McMillan SN, Pitts JRT, Barua B, Winkelmann DA, Scarff CA. Mavacamten inhibits myosin activity by stabilizing the myosin interacting-heads motif and stalling motor force generation. <i>Sci. Adv.<\/i>, <b>12<\/b>, eaea9335 (2026).","DOI":"10.1126\/sciadv.aea9335"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Pronk S, P\u00e1ll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, Van Der Spoel D, Hess B, Lindahl E. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. <i>Bioinformatics<\/i>, <b>29<\/b>, 845\u2013854 (2013).","DOI":"10.1093\/bioinformatics\/btt055"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) He X, Man VH, Yang W, Lee T-S, Wang J. A fast and high-quality charge model for the next generation general AMBER force field. <i>J. Chem. Phys.<\/i>, <b>153<\/b>, 114502 (2020).","DOI":"10.1063\/5.0019056"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. <i>Parameterization and validation. J. Comput. Chem.<\/i>, <b>23<\/b>, 1623\u20131641 (2002).","DOI":"10.1002\/jcc.10128"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Sousa da Silva AW, Vranken WF. ACPYPE\u2014AnteChamber PYthon Parser interfacE. <i>BMC Res. Notes<\/i>, <b>5<\/b>, 367 (2012).","DOI":"10.1186\/1756-0500-5-367"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) J\u00f3j\u00e1rt B, Martinek TA. Performance of the general amber force field in modeling aqueous POPC membrane bilayers. <i>J. Comput. Chem.<\/i>, <b>28<\/b>, 2051\u20132058 (2007).","DOI":"10.1002\/jcc.20748"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Kerns SJ, Agafonov RV, Cho Y-J, Pontiggia F, Otten R, Pachov DV, Kutter S, Phung LA, Murphy PN, Thai V, Alber T, Hagan MF, Kern D. The energy landscape of adenylate kinase during catalysis. <i>Nat. Struct. Mol. Biol.<\/i>, <b>22<\/b>, 124\u2013131 (2015).","DOI":"10.1038\/nsmb.2941"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Musliha A, Dermawan D, Rahayu P, Tjandrawinata RR. Unraveling modulation effects on albumin synthesis and inflammation by striatin, a bioactive protein fraction isolated from <i>Channa striata: In silico<\/i> proteomics and <i>in vitro<\/i> approaches. <i>Heliyon<\/i>, <b>10<\/b>, e38386 (2024).","DOI":"10.1016\/j.heliyon.2024.e38386"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. <i>J. Chem. Phys.<\/i>, <b>103<\/b>, 8577\u20138593 (1995).","DOI":"10.1063\/1.470117"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Ke Q, Gong X, Liao S, Duan C, Li L. Effects of thermostats\/barostats on physical properties of liquids by molecular dynamics simulations. <i>J. Mol. Liq.<\/i>, <b>365<\/b>, 120116 (2022).","DOI":"10.1016\/j.molliq.2022.120116"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Ridruejo A, Pacios LF, Arguelles J, Hayashi CY, Elices M, Guinea GV, P\u00e9rez-Rigueiro J. Elastomeric behavior of the <i>Bombyx mori<\/i> fibroin (GAGAGS)n tandem motifs. <i>J. Mech. Behav. Biomed. Mater.<\/i>, <b>168<\/b>, 107002 (2025).","DOI":"10.1016\/j.jmbbm.2025.107002"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Borjian Boroujeni M, Shahbazi Dastjerdeh M, Shokrgozar M, Rahimi H, Omidinia E. Computational driven molecular dynamics simulation of keratinocyte growth factor behavior at different pH conditions. <i>Inform. Med. Unlocked<\/i>, <b>23<\/b>, 100514 (2021).","DOI":"10.1016\/j.imu.2021.100514"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Alotaiq N, Dermawan D. Computational investigation of montelukast and its structural derivatives for binding affinity to dopaminergic and serotonergic receptors: Insights from a comprehensive molecular simulation. <i>Pharmaceuticals<\/i>, <b>18<\/b>, 559 (2025).","DOI":"10.3390\/ph18040559"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Tjandrawinata RR, Cahyana AH, Nugroho AO, Adi IK, Talpaneni JSR. Structure identification and risk assurance of unknown impurities in pramipexole oral drug formulation. <i>Adv. Pharmacol. Pharm. Sci.<\/i>, <b>2024<\/b>, 5583526 (2024).","DOI":"10.1155\/2024\/5583526"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Al-Karmalawy AA, Dahab MA, Metwaly AM, Elhady SS, Elkaeed EB, Eissa IH, Darwish KM. Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting the <i>h<\/i>ACE2 receptor. <i>Front. Chem.<\/i>, <b>9<\/b>, 661230 (2021).","DOI":"10.3389\/fchem.2021.661230"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Kurniawan R, Taslim NA, Hardinsyah H, Syauki AY, Idris I, Aman AM, Permatasari HK, Wiyarta E, Surya R, Mayulu N, Putra PP, Tjandrawinata RR, Tallei TE, Kim B, Tsopmo A, Nurkolis F. Pharmacoinformatics and cellular studies of algal peptides as functional molecules to modulate type-2 diabetes markers. <i>Future Foods<\/i>, <b>9<\/b>, 100354 (2024).","DOI":"10.1016\/j.fufo.2024.100354"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Dermawan D, Alotaiq N. Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: molecular docking and dynamics insights. <i>Sci. Rep.<\/i>, <b>15<\/b>, 8896 (2025).","DOI":"10.1038\/s41598-025-93683-1"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Simatupang ST, Dermawan D, Nadia N, Tjandrawinata RR, Tan S.  Network pharmacology and molecular dynamics studies unveil the therapeutic mechanisms of <i>Zingiber officinale<\/i> against dyspepsia. <i>J. Appl. Biol. Biotechnol.<\/i>, <b>16<\/b>, 1 (2025).","DOI":"10.7324\/JAPS.2025.240961"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Wicaksono D, Taslim NA, Lau V, Syahputra RA, Alatas AI, Putra PP, Tallei TE, Tjandrawinata RR, Tsopmo A, Kim B, Nurkolis F. Elucidation of anti-human melanoma and anti-aging mechanisms of compounds from green seaweed <i>Caulerpa racemosa<\/i>. <i>Sci. Rep.<\/i>, <b>14<\/b>, 27534 (2024).","DOI":"10.1038\/s41598-024-78464-6"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Lau V, Nurkolis F, Park MN, Heriyanto DS, Taslim NA, Tallei TE, Permatasari HK, Tjandrawinata RR, Moon S, Kim B. Green seaweed <i>Caulerpa racemosa<\/i> as a novel non-small cell lung cancer inhibitor in overcoming tyrosine kinase inhibitor resistance: An analysis employing network pharmacology, molecular docking, and <i>in vitro<\/i> research. <i>Mar. Drugs.<\/i>, <b>22<\/b>, 272 (2024).","DOI":"10.3390\/md22060272"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. <i>Expert Opin. Drug Discov.<\/i>, <b>10<\/b>, 449\u2013461 (2015).","DOI":"10.1517\/17460441.2015.1032936"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Durham E, Dorr B, Woetzel N, Staritzbichler R, Meiler J. Solvent accessible surface area approximations for rapid and accurate protein structure prediction. <i>J. Mol. Model.<\/i>, <b>15<\/b>, 1093\u20131108 (2009).","DOI":"10.1007\/s00894-009-0454-9"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Xu H, Salba, Hou Z, Liao J-L. Dissociation mechanism of inactive NLRP3 assembly revealed by protein-protein-protein binding free-energy calculations. <i>Chin. J. Chem. Phys.<\/i>, <b>38<\/b>, 356\u2013367 (2025).","DOI":"10.1063\/1674-0068\/cjcp2409122"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. <i>J. Chem. Theory Comput.<\/i>, <b>17<\/b>, 6281\u20136291 (2021).","DOI":"10.1021\/acs.jctc.1c00645"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. <i>Nucleic Acids Res.<\/i>, <b>29<\/b>, 308\u2013311 (2001).","DOI":"10.1093\/nar\/29.1.308"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Hart RK, Fokkema IFAC, DiStefano M, Hastings R, Laros JFJ, Taylor R, Wagner AH, Den Dunnen JT. HGVS Nomenclature 2024: improvements to community engagement, usability, and computability. <i>Genome Med.<\/i>, <b>16<\/b>, 149 (2024).","DOI":"10.1186\/s13073-024-01421-5"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, Rehm HL, MacArthur DG, O\u2019Donnell-Luria A. Variant interpretation using population databases: lessons from gnomAD. <i>Hum. Mutat.<\/i>, <b>43<\/b>, 1012\u20131030 (2022).","DOI":"10.1002\/humu.24309"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Abouzied AS, Alqarni S, Younes KM, Alanazi SM, Alrsheed DM, Alhathal RK, Huwaimel B, Elkashlan AM. Structural and free energy landscape analysis for the discovery of antiviral compounds targeting the cap-binding domain of influenza polymerase PB2. <i>Sci. Rep.<\/i>, <b>14<\/b>, 25441 (2024).","DOI":"10.1038\/s41598-024-69816-3"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Zhang L, Wang P, Yang Z, Du F, Li Z, Wu C, Fang A, Xu X, Zhou G. Molecular dynamics simulation exploration of the interaction between curcumin and myosin combined with the results of spectroscopy techniques. <i>Food Hydrocoll.<\/i>, <b>101<\/b>, 105455 (2020).","DOI":"10.1016\/j.foodhyd.2019.105455"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) K\u00f6hler J, Winkler G, Schulte I, Scholz T, McKenna W, Brenner B, Kraft T. Mutation of the myosin converter domain alters cross-bridge elasticity. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>99<\/b>, 3557\u20133562 (2002).","DOI":"10.1073\/pnas.062415899"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Robert-Paganin J, Auguin D, Houdusse A. Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition. <i>Nat. Commun.<\/i>, <b>9<\/b>, 4019 (2018).","DOI":"10.1038\/s41467-018-06191-4"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Mobley DL, Dill KA. Binding of small-molecule ligands to proteins: \u201cwhat you see\u201d is not always \u201cwhat you get\u201d. <i>Structure<\/i>, <b>17<\/b>, 489\u2013498 (2009).","DOI":"10.1016\/j.str.2009.02.010"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Bloemink M, Deacon J, Langer S, Vera C, Combs A, Leinwand L, Geeves MA. The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac \u03b2-myosin. <i>J. Biol. Chem.<\/i>, <b>289<\/b>, 5158\u20135167 (2014).","DOI":"10.1074\/jbc.M113.511204"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Kim O-H, Kim J, Kim Y, Lee S, Lee BH, Kim B-J, Park H-Y, Park M-H. Exploring novel <i>MYH7<\/i> gene variants using <i>in silico<\/i> analyses in Korean patients with cardiomyopathy. <i>BMC Med. Genomics<\/i>, <b>17<\/b>, 225 (2024).","DOI":"10.1186\/s12920-024-02000-8"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Auguin D, Robert-Paganin J, R\u00e9ty S, Kikuti C, David A, Theumer G, Schmidt AW, Kn\u00f6lker H-J, Houdusse A. Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction. <i>Nat. Commun.<\/i>, <b>15<\/b>, 4885 (2024).","DOI":"10.1038\/s41467-024-47587-9"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Bogomolovas J, Chen J. A therapeutic leap: how myosin inhibitors moved from cardiac interventions to skeletal muscle myopathy solutions. <i>J. Clin. Invest.<\/i>, <b>134<\/b>, e179958 (2024).","DOI":"10.1172\/JCI179958"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b26-00025\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:39:16Z","timestamp":1780112356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b26-00025\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00025","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"article-number":"b26-00025"}}